Nvelop Therapeutics

Nvelop Therapeutics

生物技术研究

Cambridge,Massachusetts 7,483 位关注者

Unlocking the full potential of genetic medicines.

关于我们

At?Nvelop, we are working to address the complex challenge of effectively delivering?genetic medicines to target cells within the body (in vivo) in order to help treat patients with previously undruggable diseases. Our team is advancing two next-generation delivery platforms, started in the?labs of our scientific co-founders?Dr. David Liu of the Broad Institute of MIT and Harvard, and Dr. Keith Joung formerly of Mass General Hospital. We will use these platforms to build a pipeline of therapeutics internally and to enable strategic partners. We are building a?culture and organization to support this important?mission,?bringing together individuals that thrive in a supportive environment where diverse perspectives and a passion for discovery drive cutting-edge science and breakthrough medicines. Read something that resonates? Reach out to [email protected].

网站
https://www.nveloptx.com/
所属行业
生物技术研究
规模
51-200 人
总部
Cambridge,Massachusetts
类型
私人持股
创立
2022

地点

  • 主要

    100 Technology Square

    US,Massachusetts,Cambridge,02139

    获取路线

Nvelop Therapeutics员工

动态

相似主页

融资